Navigation Links
Dendreon Publishes Manuscript on CD54 as a Surrogate Marker of Antigen Presenting Cell Activation
Date:3/3/2008

SEATTLE, March 3 /PRNewswire-FirstCall/-- Dendreon Corporation (Nasdaq: DNDN) announced the publication of a manuscript titled, "CD54 is a surrogate marker of antigen presenting cell activation" in Cancer Immunology, Immunotherapy.

The manuscript describes and supports the use of CD54 as a surrogate marker of antigen presenting cell activation (APC) activation and validates its utility as a potency measure of PROVENGE(R) (sipuleucel-T). In particular, it describes how Dendreon researchers used CD54 and the upregulation of its expression on antigen presenting cells (APC) as a means by which human APC activation could be assessed and most importantly, how such measurements could be used to determine the potency of PROVENGE before its administration to patients with prostate cancer. The assessment of product potency is a key release measure required by the U.S. Food and Drug Administration (FDA).

The upregulation of CD54 has been used as part of the potency assay for PROVENGE since the initiation of the PROVENGE clinical development program. Data correlating CD54 upregulation to overall survival in patients from two Phase 3 trials, D9901 and D9902A have been presented at recent scientific meetings and at the FDA Cell Tissue and Gene Therapy Advisory Committee Meeting on March 29, 2007.

About Active Cellular Immunotherapy with PROVENGE

PROVENGE may represent the first product in a new class of active cellular immunotherapies (ACIs) that are uniquely designed to use live human cells to engage the patient's own immune system with the goal of eliciting a specific long-lasting response against cancer. In clinical studies, patients typically received three doses of PROVENGE over a one-month period as a complete course of therapy.

About Dendreon

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics that
'/>"/>

SOURCE Dendreon Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Dendreon Announces Webcast Presentation at UBS Life Sciences Conference
3. Dendreon Secures $130 Million Committed Equity Financing Facility
4. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
5. Dendreon Reports Third Quarter 2007 Financial Results
6. Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer
7. Dendreon Announces Webcast Presentation at BIO CEO & Investor Conference
8. Circulation Publishes MERLIN TIMI-36 Data Showing Safety and Anti-Arrhythmic Effects of Ranexa(R)
9. Thomson Scientific Publishes Who Is Making The Biggest Splash? - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007
10. Consortium publishes Phase II map of human genetic variation
11. The Lancet Publishes Vasogens ACCLAIM Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2009)...h Chief Master Sergeant in Air Force History Appoi..., , VIENNA, Va., July 1 /PRNewswire-USNewswire/... Master Sergeant of the Air Force (CMSAF) Rod McKi...esident of Strategic Partnerships. MicroTech is o...e management providers in the U.S. In his new role...
(Date:7/1/2009)... NeoStem, Inc. (NYSE Amex...ional gross funds of over $4 million from institut... with the $11 million private placement from three...ing the total investment obtained by NeoStem in th...n addition, affiliates of Suzhou Erye Pharmaceutic...
(Date:6/30/2009)... summer grass that tickles your feet or the red Bo... of the world around you carries special chemical ...scientists where the molecules that compose a subs...ened to them along the way. But doing these analys...ists have developed a new method to make isotopic ...
(Date:6/30/2009)...une 30 In connection wit...of abuse testing company Concateno plc, announced .... (NYSE: IMA ) has been requested by the UK Take...h this announcement of their dealing disclosure ob..., , Dealing disclosure requirements of the UK ...
Breaking Biology Technology:Air Force Chief Master Sergeant Rod McKinley (U.S. Air Force Retired) Joins MicroTech as Vice President of Strategic Partnerships 2Air Force Chief Master Sergeant Rod McKinley (U.S. Air Force Retired) Joins MicroTech as Vice President of Strategic Partnerships 3NeoStem Raises Additional Funds from Principals of Suzhou Erye Pharmaceuticals Company Ltd. and U.S. Institutional and Private Investors, Bringing the Total Recent Financings to Over $15 Million; Funds Will Support Expansion Activities in the United State 2NeoStem Raises Additional Funds from Principals of Suzhou Erye Pharmaceuticals Company Ltd. and U.S. Institutional and Private Investors, Bringing the Total Recent Financings to Over $15 Million; Funds Will Support Expansion Activities in the United State 3Stanford researchers find a quicker, cheaper way to sort isotopes 2Stanford researchers find a quicker, cheaper way to sort isotopes 3Inverness Medical Innovations - Concateno plc, Further Announcement Regarding UK Takeover Code Share Dealing Disclosure Requirements. 2
... , , , , , , , ...n,the Eberwine Target Preparation Workflow , ...nd sensitivity are key parameters for the,qualit...,improved reliability of commercially available mi...et preparation as a,critical step in microarray ...
... , , , , , , ,...s have been the,subject of large-scale genome pr...ene sequences are now ready,for functional analy... particular genes is key to understanding,gene f...rrays and similar high-throughput gene expression,...
... , , , , , , ,...w larger pack sizes,of PCR-Grade Nucleotides. Th... quality with attractive pricing. , , ... , , , Single dNTPs are now availabl...phosphate Set, containing all four dNTPs (dATP, dC...
... , , , , , , ,...RPA) is a highly sensitive,and specific method f...s. The assay was made possible,by the discovery ...-dependent RNA polymerases (SP6, T7,and T3). Th... them well suited for the preparation of highly sp...
Other Biology Technology:Increased Sensitivity in Microarray Analysis 2Increased Sensitivity in Microarray Analysis 3The DIG System Nonradioactive Automated,High-Throughput In Situ Hybridization:,a Powerful Tool for Functional Genomics Research 2The DIG System Nonradioactive Automated,High-Throughput In Situ Hybridization:,a Powerful Tool for Functional Genomics Research 3The DIG System Nonradioactive Automated,High-Throughput In Situ Hybridization:,a Powerful Tool for Functional Genomics Research 4The DIG System Nonradioactive Automated,High-Throughput In Situ Hybridization:,a Powerful Tool for Functional Genomics Research 5The DIG System Nonradioactive Automated,High-Throughput In Situ Hybridization:,a Powerful Tool for Functional Genomics Research 6PCR-Grade Nucleotides,Larger Pack Sizes Now Available 2RNase Protection Assay (RPA),Using DIG-Labeled RNA Probes 2
(Date:7/2/2009)... . , , A good wine needs to ripen. But it,s a ...he grapevines have to overcome all kinds of obstac...tire crops, not to mention the wide variety of pes...vine louse or the rust mite, fungi such as mildew,...(GFLV for short) can give the vines a hard time. T...
(Date:7/2/2009)...elebrates its birth on the 4th of July, University...aribbean coral reef nursery scientists will be cel...heric Administration (NOAA) today announced that T...nd elkhorn coral recovery project, including Lirma...e support from the American Recovery and Reinvestm...
(Date:7/1/2009)...en associated with the formation of metastases in ...brck Center for Molecular Medicine (MDC) Berlin-Bu..., have identified 115 genes that are disregulated ...n the future, their findings may help identify pat... Gastroenterology 2009, doi:10.1053/j.gastro.2009...
(Date:7/1/2009)...ble for repairing DNA strands damaged by oxidation...ional evidence that such stress contributes to the... recent study* in DNA Repair by researchers at t...(NIST), Oregon Health and Science University (OHSU...NYUSM). , Although all cells need oxygen to surv...
Breaking Biology News(10 mins):Virus-resistant grapevines 2Nursery programs for corals receive TLC from NOAA this Independence Day 2Colorectal cancer 2Genetically engineered mice yield clues to 'knocking out' cancer 2ThermoGenesis Announces MXP Involvement in New Regenerative Medicine Initiatives 3774 1ThermoGenesis Announces MXP Involvement in New Regenerative Medicine Initiatives 3774 2ThermoGenesis Announces MXP Involvement in New Regenerative Medicine Initiatives 3774 3ThermoGenesis Announces MXP Involvement in New Regenerative Medicine Initiatives 3774 4RediClinic Locations in Austin Added as Blue Cross and Blue Shield of Texas Network Providers 35181 1RediClinic Locations in Austin Added as Blue Cross and Blue Shield of Texas Network Providers 35181 2Covidien Canada Streamlines Integration and Processing of Fax based Orders With GHX G Fax 28TM 29 Fax Conversion Service 35178 1Covidien Canada Streamlines Integration and Processing of Fax based Orders With GHX G Fax 28TM 29 Fax Conversion Service 35178 2Covidien Canada Streamlines Integration and Processing of Fax based Orders With GHX G Fax 28TM 29 Fax Conversion Service 35178 3AMDL First to Implement US 26 China Based GAAP Certified Accounting Technology to Capitalize on Lucrative China Healthcare Market 10186 1AMDL First to Implement US 26 China Based GAAP Certified Accounting Technology to Capitalize on Lucrative China Healthcare Market 10186 2AMDL First to Implement US 26 China Based GAAP Certified Accounting Technology to Capitalize on Lucrative China Healthcare Market 10186 3AMDL First to Implement US 26 China Based GAAP Certified Accounting Technology to Capitalize on Lucrative China Healthcare Market 10186 4
...oscopic titanium particles weaken the bonding of h...to research published online in Proceedings of the...e University of California, San Diego (UCSD) Schoo.... The team demonstrated that titanium implants are...l, wear and tear can generate micrometer-sized par...
...archers have discovered a fascinating symbiotic re...overed bacterial species ?a relationship that pote...fully utilized by higher organisms in defensive me...researchers show that a solitary ground-nesting wa...teria in unique structures within its antennae and...
...g state of the art imaging technology a team from ...ll,s most important ,nano-machines, in action. The... French scientists, provides new insight into the ...ceptors. , All cells traffic protein cargos across...nt routes for cargo internalization is clathrin me...
... recent study published in the Journal of Biologic...eviously thought to play a purely structural and i...ug resistance in cancer. Using antagonists for thi... drug resistant breast cancer cells to chemotherap...he "Paper of the Week" in the May 27 issue of the ...
Other Biology News:UCSD medical/bioengineering reseachers show titanium debris satobtage artificial joints 2Symbiotic bacteria protect hunting wasps from fungal infestation 2Researchers develop assay that could be applied to drug screening 2New polysaccharide may help combat multidrug resistance in cancer 2
Human Laminin ELISA Kit, QuantiMatrix from Upstate
Agarose-LE, 250 g. Suitable for soft agarose cloning. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1200 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals .
Request Info
Request Info
Biology Products: